New hope for kids with tough blood cancers: modified transplant aims to beat disease
NCT ID NCT03849651
Summary
This study is for children and young adults (up to age 21) with high-risk blood cancers like leukemia and lymphoma. It tests a modified blood cell transplant from a partially matched family donor. The donor cells are processed in a lab to remove certain immune cells that can cause a harmful reaction, with the goal of better controlling the cancer and improving survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.